Join Us! Events Today, and Upcoming!
Core Training Webinar, “The Alphabet Soup of Grants”
When: 12 p.m. ET, Today, April 14, 2021
Register now and view archived webinars!
Industry Innovations: “Recognizing Uncontrolled Asthma Is Only the First Step”
This program will aim to provide insight into the challenges of diagnosing uncontrolled asthma, review asthma management guidelines, and identify ways to minimize the effects of uncontrolled asthma.
When: 6:30 p.m. ET, April 14, 2021
Register now!
Sponsored by GlaxoSmithKline.
Industry Innovations: “REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data”
Please join us for an exciting webinar releasing data from the Phase IV REPLACE (Riociguat rEplacing PDE-5i therapy evaLuated Against Continued PDE-5i thErapy) study.
When: 6:30 p.m. ET, April 21, 2021
Register now!
Sponsored by Bayer.
Industry Innovations: “The Role of OFEV® (nintedanib) Capsules: A Treatment Journey”
Join to review background information followed by an overview of the OFEV pivotal safety and efficacy data.
When: 6:30 p.m. ET, April 28, 2021
Register now!
Sponsored by Boehringer Ingelheim.
Upcoming Journal Club
Join the Section on Genetics and Genomics and the Assembly on Allergy, Immunology, and Inflammation to discuss, “Genetic and Non-Genetic Factors Affecting the Expression of COVID-19 Relevant Genes in the Large Airway Epithelium.”
When: 1 p.m. ET, April 23, 2021
Register now!
New Resource! Safe and Effective COVID-19 Transitions of Care
This downloadable resource was developed by a steering committee from different practice and professional settings to provide strategies, resources, and tools to enable multidisciplinary transitions of care across health care settings.
Sponsored by PRIME Education
NIH Funding Opportunities Announcement
As part of UNITE, the NIH Common Fund has issued two funding opportunities announcements to bolster innovation, solve challenges, and address health disparities and advance health equity:
- RFA-RM-21-021 Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
- RFA-RM-21-022 Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
NIH staff intend to hold a pre-application webinar for all interested prospective applicants.
Learn more and view the FAQs! If you have questions about the FOAs, please contact CFHealthDisparities@nih.gov.
Deadline: 5 p.m. ET, May 28, 2021
Last Chance to Apply!
CHEST Foundation and ATS Research Grant in COVID-19 and Diversity
Just a few days left to apply for the CHEST Foundation and ATS Research Grant in COVID-19 and Diversity!
Applications must address clinical or community-related aspects of COVID-19 that focus on an underrepresented minority patient group.
Deadline: April 16, 2021
ATS ASPIRE Fellowship
The ATS ASPIRE Fellowship aims to develop the next generation of pulmonary and sleep physician-scientists and leaders.
The program includes a collaboration between ATS and several outstanding institutions that have strong Pulmonary/Critical Care/Sleep training programs. Learn more and apply today!
Deadline: April 19, 2021
#ATS2021 Social Media Ambassadors
Do you have an active, public Twitter account, with at least 500 followers, AND plan to attend ATS 2021?
If so, apply to be an #ATS2021 Twitter ambassador!
If you are selected as an ambassador, you will:
- Live tweet at least one session, as a thread.
- Complete and post about the ATS 2021 game, San Diego Sleuth, including a screenshot of you with the prize!
- Post about your excitement for #ATS2021 starting May 1, leading up to the launch on May 14!
- Share your stories and the things you love about the annual conference!
Ambassadors will receive a personalized image to use for promotion on Twitter, retweets by @atscommunity, and a certificate of completion.
Interested? Email sfulgione@thoracic.org to apply. Please include your Twitter handle, a short bio, and a photo for the promotional image.
